Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCEORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCEENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16962.5China
GU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.9.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JV.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used